1887

Abstract

This report describes a case of ciprofloxacin treatment failure in a patient with enteric fever caused by serotype Paratyphi A. The organism was isolated from a blood culture from a patient who was treated with oral ciprofloxacin (500 mg every 12 h) for 13 days. The organism showed reduced susceptibility to ciprofloxacin (MIC 0.75 μg ml) and was resistant to nalidixic acid. The patient was then placed on intravenous ceftriaxone (1 g every 12 h) and responded within 3 days. The patient was discharged after 9 days on ceftriaxone with no relapse on follow-up. This case adds to the increasing incidence of treatment failures with ciprofloxacin in typhoid fever caused by typhoid salmonellae with reduced susceptibility to ciprofloxacin. It also highlights the inadequacy of current laboratory methods for fluoroquinolone susceptibility testing in adequately predicting activity of ciprofloxacin against typhoid salmonellae and supports calls for new guidelines for fluoroquinolone susceptibility testing of these organisms.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46773-0
2007-02-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/2/277.html?itemId=/content/journal/jmm/10.1099/jmm.0.46773-0&mimeType=html&fmt=ahah

References

  1. Asna, S. M., Hag, J. A. & Rahma, M. M. ( 2003; ). Nalidixic acid resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh. Jpn J Infect Dis 56, 32–33.
    [Google Scholar]
  2. Chandel, D. S., Chaudhry, R., Dhawan, B., Pandey, A. & Dey, A. B. ( 2000; ). Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 6, 420–421.[CrossRef]
    [Google Scholar]
  3. Dimitrov, Ts., Panigrahi, D., Emara, M., Al-Nakkas, A., Awni, F. & Passadilla, R. ( 2005; ). Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-years experience. Med Princ Pract 14, 417–421.[CrossRef]
    [Google Scholar]
  4. Giraud, E., Brisabois, A., Martel, J.-L. & Chaslus-Dancla, E. ( 1999; ). Comparative studies of mutations in animal isolates and experimental in vitro and in vivo-selected mutants of Salmonella spp. suggest a counter selection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 43, 2131–2137.
    [Google Scholar]
  5. Hakanen, A., Kotilainen, P., Jalava, J. & Siitonen, A. ( 1999; ). Detection of decreased fluoroquinolone susceptibility and validation of nalidixic acid screening test. J Clin Microbiol 37, 3572–3577.
    [Google Scholar]
  6. Hakanen, A., Kotilainen, P., Huovinen, P., Helenius, H. & Siitonen, A. ( 2001; ). Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis 7, 996–1003.[CrossRef]
    [Google Scholar]
  7. National Committee for Clinical Laboratory Standards ( 2005; ). Methods for Disk Susceptibility Tests for Bacteria that Grow Aerobically, NCCLS Document M2-A8, 7th edn. Wayne, PA: National Committee for Clinical Laboratory Standards.
  8. Nkemngu, N. J., Asonganyi, E. D. & Njunda, A. L. ( 2005; ). Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. BMC Infect Dis 5, 49.[CrossRef]
    [Google Scholar]
  9. Parry, C. M., Hien, T. T., Dougan, G., White, N. J. & Farrar, J. J. ( 2002; ). Typhoid fever. N Engl J Med 347, 17–82.
    [Google Scholar]
  10. Piddock, L. J. ( 2002; ). Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev 26, 3–16.[CrossRef]
    [Google Scholar]
  11. Poutanen, S. & Low, D. E. ( 2003; ). Is it time to change fluoroquinolones MIC breakpoints for Salmonella spp.? Clin Microbiol Newsl 25, 97–102.[CrossRef]
    [Google Scholar]
  12. Threlfall, E. J. & Ward, L. R. ( 2001; ). Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Emerg Infect Dis 7, 448–450.[CrossRef]
    [Google Scholar]
  13. Umasankar, S., Wall, R. A. & Berger, J. ( 1992; ). A case of ciprofloxacin-resistant typhoid fever. CDR Rev 2, R139–140.
    [Google Scholar]
  14. Wain, J., Hoa, N. T. T., Chinh, N. T., Vinh, H., Everett, M. J. & Diep, T. S. ( 1997; ). Quinolone-resistant Salmonella typhi in Vietnam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 25, 1404–1410.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46773-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error